The innovation drug sector is active again, Sile Medical has hit the daily limit.

The innovative pharmaceutical sector is active again, with Celgene Medical hitting the limit up, and companies such as San Yuan Genetics, Medis, Pras, Rui Zhi Medical, and Asia Pacific Pharmaceuticals following suit.